©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessHyperlipidaemias/Dyslipidaemias, familial; differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for familial Hyperlipidemia comprising 13 guideline-curated and altogether 22 curated genes according to the clinical signs

ID
HP0720
Number of genes
22 Accredited laboratory test
Examined sequence length
32,7 kb (Core-/Core-canditate-Genes)
48,1 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ABCA16786NM_005502.4AR
APOA51101NM_052968.5AD, AR
APOB13692NM_000384.3AD, AR
APOC2306NM_000483.5AR
CREB3L31386NM_032607.3AD
GPD11050NM_005276.4AR
GPIHBP1555NM_178172.6AR
LDLR2583NM_000527.5AD
LMF11704NM_022773.4AR
LPL1428NM_000237.3AD, AR
PCSK92079NM_174936.4AD
ABCG51956NM_022436.3AR
ABCG82022NM_022437.3AR
APOE954NM_000041.4AD, AR
CETP1482NM_000078.3AD
CYP27A11596NM_000784.4AR
CYP7A11515NM_000780.4AR
LCAT1323NM_000229.2AR
LDLRAP1927NM_015627.3AR
LIPA1200NM_000235.4AR
LIPC1500NM_000236.3AR
USF1933NM_007122.5AD

Informations about the disease

Clinical Comment

Hyperlipidemia involves an imbalance of cholesterol levels, including low-density lipoprotein cholesterol (LDL-C) + high-density lipoprotein cholesterol (HDL-C) in blood

 

Synonyms
  • Alias: Familial hyperlipidemia
  • Alias: Rare hyperlipidemia
  • Allelic: Alzheimer disease 2 (APOE)
  • Allelic: Alzheimer disease, protection against, due to APOE3-Christchurch APOE)
  • Allelic: Diabetes mellitus, noninsulin-dependent (LIPC)
  • Allelic: Gallbladder disease 4 (ABCG8)
  • Allelic: Hypobetalipoproteinemia (APOB)
  • Allelic: Sea-blue histiocyte disease (APOE)
  • Cerebrotendinous xanthomatosis (CYP27A1)
  • Cholesteryl ester storage disease (LIPA)
  • Combined hyperlipidemia, familial (LPL)
  • Coronary artery disease, severe, susceptibility to (APOE)
  • Familial combined hyperlipoproteinaemia, inherited mixed hyperlipidaemias [panelapp] (USF1)
  • Fish-eye disease (LCAT)
  • HDL deficiency, familial, 1 (ABCA1)
  • Hepatic lipase deficiency (LIPC)
  • High density lipoprotein cholesterol level QTL 10 (CETP)
  • High density lipoprotein cholesterol level QTL 11 (LPL)
  • High density lipoprotein cholesterol level QTL 12 (LIPC)
  • Hyperalphalipoproteinemia (CETP)
  • Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (CYP7A1)
  • Hypercholesterolemia, familial, 1 (LDLR)
  • Hypercholesterolemia, familial, 2 (APOB)
  • Hypercholesterolemia, familial, 3 (PCSK9)
  • Hypercholesterolemia, familial, 4 (LDLRAP1)
  • Hyperchylomicronemia, late-onset (APOA5)
  • Hyperlipidemia, familial combined, susceptibility to (USF1)
  • Hyperlipoproteinemia, type 1D (GPIHBP1)
  • Hyperlipoproteinemia, type III (APOE)
  • Hyperlipoproteinemia, type Ib (APOC2)
  • Hypertriglyceridemia 2 (CREB3L3)
  • Hypertriglyceridemia disease [MONDO:0005347] (LIPI)
  • Hypertriglyceridemia, susceptibility to (APOA5)
  • Hypertriglyceridemia, transient infantile (GPD1)
  • LDL cholesterol level QTL2 (LDLR)
  • Lipase deficiency, combined (LMF1)
  • Lipoprotein glomerulopathy (APOE)
  • Lipoprotein lipase deficiency (LPL)
  • Low density lipoprotein cholesterol level QTL 1 (PCSK9)
  • Macular degeneration, age-related (APOE)
  • Monogenic dominant hypertriglyceridemia associated with (CREB3L3)
  • Norum disease (LCAT)
  • Sitosterolemia 1 (ABCG8)
  • Sitosterolemia 2 (ABCG5)
  • Tangier disease (ABCA1)
  • Wolman disease (LIPA)
Heredity, heredity patterns etc.
  • AD
  • AR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined